The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea

Diarrhea is one of the most commonly reported adverse effect of hemotherapy and targeted cancer therapies, such as tyrosine kinase inhibitors (TKI), which often significantly impact patient quality of life, morbidity, and mortality. Neratinib is an oral, irreversible pan‐HER tyrosine kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Lysyy, Taras, Lalani, Alshad S., Olek, Elizabeth A., Diala, Irmina, Geibel, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743423/
https://www.ncbi.nlm.nih.gov/pubmed/31523434
http://dx.doi.org/10.1002/prp2.521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743423/
https://www.ncbi.nlm.nih.gov/pubmed/31523434
http://dx.doi.org/10.1002/prp2.521

Ejemplares similares